94 results
Page 4 of 5
S-4/A
z6xbllkkmvyws
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.16
zaomldzzymh34gf0a1
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-8.1
ck9soze
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.16
24tbddhfkmhrztdnuhfe
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
bscgrhma42o937j2
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.11
lt1i6l9xim
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
lroy yxyp7
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K
EX-99.1
8ws9nsx wi2p
15 Mar 21
Public Investor Presentation Transcript
5:20pm
425
5p0p538te
15 Mar 21
Business combination disclosure
8:20am
8-K
a2a0 q2qkdzvzll
15 Mar 21
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
8:19am
10-K
tqjd gmv4o6q
5 Mar 21
Annual report
8:13am
10-Q
cnv187pq3hog
20 Aug 20
Quarterly report
4:15pm
8-K
EX-99.1
hnatnls
16 Jul 20
Report of Independent Registered Public Accounting Firm
4:30pm
8-K
EX-10.2
rspusismu6
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm